论文部分内容阅读
目的 :观察山水复元口服液治疗气虚血瘀型脑血栓形成的临床疗效。方法 :采用随机对照方法 ,对 5 0例气虚血瘀型脑血栓形成患者用山水复元口服液治疗 (治疗组 ) ,另 5 0例用太极通天口服液治疗 (对照组 ) ,比较 2组的疗效和血液流变性及血脂变化。结果 :治疗组基本痊愈 8例 (16 .0 % ) ,显效 2 5例 (5 0 .0 % ) ,有效 12例(2 4.0 % ) ,总有效率 90 .0 % ;对照组基本痊愈 5例 (10 .0 % ) ,显效 15例 (30 .0 % ) ,有效 13例 (2 6 .0 % ) ,总有效率 6 6 .0 %。 2组总有效率比较有显著性差异 (P<0 .0 5 )。山水复元口服液还能明显改善患者的临床症状 ,治疗后血液流变学指标和血脂较治疗前和对照组治疗后均明显改善 (P均 <0 .0 5 ) ;治疗期间未发现不良反应。结论 :山水复元口服液治疗气虚血瘀型脑血栓形成有较好的疗效
Objective: To observe the clinical effect of Shanshui Fuyuan oral liquid in treating cerebral thrombosis with qi deficiency and blood stasis. Methods: Fifty cases of cerebral thrombosis with qi deficiency and blood stasis were treated with Shanshui Fuyuan oral liquid (treatment group) and another 50 cases were treated with Taiji Tongtian oral liquid (control group). The curative effect was compared between the two groups And blood rheology and blood lipid changes. Results: The treatment group basically recovered in 8 cases (16.0%), effective in 25 cases (50.0%), effective in 12 cases (2.04%), the total effective rate was 90.0%; the control group basically recovered in 5 cases (10.0%), 15 (30.0%) were effective, 13 (26.0%) were effective and the total effective rate was 66.0%. The total effective rate in the two groups was significantly different (P <0.05). Shanshui Fuyuan oral liquid can also significantly improve the clinical symptoms of patients. After treatment, the indexes of hemorheology and blood lipids were significantly improved (P <0.05) before and after treatment. No adverse reactions were found during the treatment. Conclusion: Shanshui Fuyuan oral liquid treatment of cerebral thrombosis Qi deficiency and blood stasis have a good effect